AOC-1045

N/A

Report date: 2025/04/16 16:18:03

Base Information

Drug NameAOC-1045

Drug Alias NameAOC-1045

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate

Mechanisms of ActionDystrophin expression stimulants

TargetsDystrophin

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAvidity Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAvidity Biosciences Inc

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A